Amryt Pharma is quoted on the London Stock Exchange’s AIM Market and the Irish Stock Exchange’s Enterprise Securities Market.

Major Shareholders

Major shareholders are as follows (interest as at 1 June 2018).

Name Number of shares Percentage of issued share capital
Software AG-Stiftung 61,272,920 22.30%
Axa Framlington 26,940,370 9.80%
Raglan Road Capital 24,697,347 8.99%
Joseph Wiley 20,994,487 7.64%
Legal & General 14,250,000 5.19%
Amati 13,205,882 4.80%
Rory Nealon 9,664,623 3.52%
Alan Harris 8,869,090 3.23%

There are a total of 274,817,283 shares in issue and no shares held in treasury. Pursuant to the AIM Rules, and insofar as the Company is aware, as at 1 June 2018, 43.49% of the Company’s AIM securities were not in public hands.

Restrictions: there are no restrictions on the transfer of Ordinary Shares.
Takeover Code: the Company is subject to the City Code on Takeovers and Mergers.